Intravitreal bevacizumab and triamcinolone for treatment of cystoid macular oedema associated with chronic myeloid leukaemia and imatinib therapy.
Purpose. To evaluate the efficacy of intravitreal bevacizumab and triamcinolone in the treatment of cystoid macular oedema in a case with chronic myeloid leukaemia on imatinib treatment. Methods. We treated a 78-year-old man with bilateral cystoid macular oedema with intravitreal triamcinolone and subsequent bevacizumab in one eye and intravitreal bevacizumab, alone, in the fellow eye. Results. Serial intravitreal bevacizumab with and without triamcinolone treated cystoid macular oedema in both eyes and improved the vision. Conclusion. Intravitreal bevacizumab and triamcinolone could be viable options to treat cystoid macular oedema due to chronic myeloid leukaemia and imatinib therapy.
Department of Ophthalmology, Gloucester Royal Hospital, Gloucester GL1 3NN, UK.
Eric K
EK
Newcott
Department of Ophthalmology, Gloucester Royal Hospital, Gloucester GL1 3NN, UK.
Abdallah A
AA
Ellabban
Department of Ophthalmology, Gloucester Royal Hospital, Gloucester GL1 3NN, UK.
Shokufeh
S
Tavassoli
Department of Ophthalmology, Gloucester Royal Hospital, Gloucester GL1 3NN, UK.
Ahmed
A
Sallam